Nagamachi Y - Search Results

1

Characterization of the MADH2/Smad2 gene, a human Mad homolog responsible for the transforming growth factor-beta and activin signal transduction pathway.

Takenoshita S, Mogi A, Nagashima M, Yang K, Yagi K, Hanyu A, Nagamachi Y, Miyazono K, Hagiwara K. Takenoshita S, et al. Among authors: nagamachi y. Genomics. 1998 Feb 15;48(1):1-11. doi: 10.1006/geno.1997.5149. Genomics. 1998. PMID: 9503010

2

Absence of mutatins in the analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic humangastric cancer using genomic DNA and intron primers.

Takenoshita S, Mogi A, Osawa H, Sunaga H, Kakegawa H, Tani M, Morinaga N, Kato R, Hagiwara K, Nagamachi Y. Takenoshita S, et al. Among authors: nagamachi y. Oncol Rep. 1998 Jan-Feb;5(1):77-80. doi: 10.3892/or.5.1.77. Oncol Rep. 1998. PMID: 9458298

3

Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers.

Takenoshita S, Tani M, Mogi A, Nagashima M, Nagamachi Y, Bennett WP, Hagiwara K, Harris CC, Yokota J. Takenoshita S, et al. Among authors: nagamachi y. Carcinogenesis. 1998 May;19(5):803-7. doi: 10.1093/carcin/19.5.803. Carcinogenesis. 1998. PMID: 9635866

4

Isolation of a novel Sry-related gene that is expressed in high-metastatic K-1735 murine melanoma cells.

Tani M, Shindo-Okada N, Hashimoto Y, Shiroishi T, Takenoshita S, Nagamachi Y, Yokota J. Tani M, et al. Among authors: nagamachi y. Genomics. 1997 Jan 1;39(1):30-7. doi: 10.1006/geno.1996.4483. Genomics. 1997. PMID: 9027483

5

Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions.

Tani M, Takenoshita S, Kohno T, Hagiwara K, Nagamachi Y, Harris CC, Yokota J. Tani M, et al. Among authors: nagamachi y. Carcinogenesis. 1997 May;18(5):1119-21. doi: 10.1093/carcin/18.5.1119. Carcinogenesis. 1997. PMID: 9163705

6

Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.

Takenoshita S, Mogi A, Tani M, Osawa H, Sunaga H, Kakegawa H, Yanagita Y, Koida T, Kimura M, Fujita KI, Kato H, Kato R, Nagamachi Y. Takenoshita S, et al. Among authors: nagamachi y. Oncol Rep. 1998 Mar-Apr;5(2):367-71. Oncol Rep. 1998. PMID: 9468559

7

Mutation of the transforming growth factor-beta type II receptor gene is a rare event in human sporadic gastric carcinomas.

Shitara Y, Yokozaki H, Yasui W, Takenoshita S, Nagamachi Y, Tahara E. Shitara Y, et al. Among authors: nagamachi y. Int J Oncol. 1998 May;12(5):1061-5. doi: 10.3892/ijo.12.5.1061. Int J Oncol. 1998. PMID: 9538129

8

No mutations of the Smad2 gene in human sporadic gastric carcinomas.

Shitara Y, Yokozaki H, Yasui W, Takenoshita S, Kuwano H, Nagamachi Y, Tahara E. Shitara Y, et al. Among authors: nagamachi y. Jpn J Clin Oncol. 1999 Jan;29(1):3-7. doi: 10.1093/jjco/29.1.3. Jpn J Clin Oncol. 1999. PMID: 10073143

9

Evidence that the aberrant alpha 1-->2fucosyltransferase found in colorectal carcinoma may be encoded by Fuc-TIII (Le) gene.

Nakamura J, Mogi A, Asao T, Nagamachi Y, Yazawa S. Nakamura J, et al. Among authors: nagamachi y. Anticancer Res. 1997 Nov-Dec;17(6D):4563-9. Anticancer Res. 1997. PMID: 9494569

10

[Lymphoid hyperplastic diseases of the intestine, lymphoid hyperplasia of the intestine, malignant lymphoma of the intestine, and Burkitt's lymphoma of the intestine].

Nagamachi Y, Takenoshita S. Nagamachi Y, et al. Ryoikibetsu Shokogun Shirizu. 1994;(6):595-8. Ryoikibetsu Shokogun Shirizu. 1994. PMID: 7736147 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters